These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24221084)

  • 1. TDAG8 activation inhibits osteoclastic bone resorption.
    Hikiji H; Endo D; Horie K; Harayama T; Akahoshi N; Igarashi H; Kihara Y; Yanagida K; Takeda J; Koji T; Shimizu T; Ishii S
    FASEB J; 2014 Feb; 28(2):871-9. PubMed ID: 24221084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosine inhibits osteoclastogenesis and bone resorption via G protein-coupled receptor 65.
    Ahn SH; Lee SY; Baek JE; Lee SY; Park SY; Lee YS; Kim H; Kim BJ; Lee SH; Koh JM
    J Endocrinol Invest; 2015 Aug; 38(8):891-9. PubMed ID: 25841894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
    Idris AI; Landao-Bassonga E; Ralston SH
    Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption.
    Karsdal MA; Henriksen K; Sørensen MG; Gram J; Schaller S; Dziegiel MH; Heegaard AM; Christophersen P; Martin TJ; Christiansen C; Bollerslev J
    Am J Pathol; 2005 Feb; 166(2):467-76. PubMed ID: 15681830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells.
    Kameda T; Mano H; Yamada Y; Takai H; Amizuka N; Kobori M; Izumi N; Kawashima H; Ozawa H; Ikeda K; Kameda A; Hakeda Y; Kumegawa M
    Biochem Biophys Res Commun; 1998 Apr; 245(2):419-22. PubMed ID: 9571166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption.
    van der Eerden BC; Hoenderop JG; de Vries TJ; Schoenmaker T; Buurman CJ; Uitterlinden AG; Pols HA; Bindels RJ; van Leeuwen JP
    Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17507-12. PubMed ID: 16291808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free Fatty Acid Receptor 4 (GPR120) Stimulates Bone Formation and Suppresses Bone Resorption in the Presence of Elevated n-3 Fatty Acid Levels.
    Ahn SH; Park SY; Baek JE; Lee SY; Baek WY; Lee SY; Lee YS; Yoo HJ; Kim H; Lee SH; Im DS; Lee SK; Kim BJ; Koh JM
    Endocrinology; 2016 Jul; 157(7):2621-35. PubMed ID: 27145004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
    Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
    Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The resorptive apparatus of osteoclasts supports lysosomotropism and increases potency of basic versus non-basic inhibitors of cathepsin K.
    Fuller K; Lindstrom E; Edlund M; Henderson I; Grabowska U; Szewczyk KA; Moss R; Samuelsson B; Chambers TJ
    Bone; 2010 May; 46(5):1400-7. PubMed ID: 20097319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contextual tumor suppressor function of T cell death-associated gene 8 (TDAG8) in hematological malignancies.
    Justus CR; Sanderlin EJ; Dong L; Sun T; Chi JT; Lertpiriyapong K; Yang LV
    J Transl Med; 2017 Oct; 15(1):204. PubMed ID: 29017562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinoxaline derivative of oleanolic acid inhibits osteoclastic bone resorption and prevents ovariectomy-induced bone loss.
    Zhao Y; Huai Y; Jin J; Geng M; Li JX
    Menopause; 2011 Jun; 18(6):690-7. PubMed ID: 21228726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
    Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
    Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation.
    Zaiss MM; Sarter K; Hess A; Engelke K; Böhm C; Nimmerjahn F; Voll R; Schett G; David JP
    Arthritis Rheum; 2010 Aug; 62(8):2328-38. PubMed ID: 20506516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chloride channel inhibitor NS3736 [corrected] prevents bone resorption in ovariectomized rats without changing bone formation.
    Schaller S; Henriksen K; Sveigaard C; Heegaard AM; Hélix N; Stahlhut M; Ovejero MC; Johansen JV; Solberg H; Andersen TL; Hougaard D; Berryman M; Shiødt CB; Sørensen BH; Lichtenberg J; Christophersen P; Foged NT; Delaissé JM; Engsig MT; Karsdal MA
    J Bone Miner Res; 2004 Jul; 19(7):1144-53. PubMed ID: 15176998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of T cell death-associated gene 8 regulates the cytokine production of T cells and macrophages in vitro.
    Onozawa Y; Fujita Y; Kuwabara H; Nagasaki M; Komai T; Oda T
    Eur J Pharmacol; 2012 May; 683(1-3):325-31. PubMed ID: 22445881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of platelet-activating factor receptor protects mice from osteoporosis following ovariectomy.
    Hikiji H; Ishii S; Shindou H; Takato T; Shimizu T
    J Clin Invest; 2004 Jul; 114(1):85-93. PubMed ID: 15232615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A distinctive role of the leukotriene B4 receptor BLT1 in osteoclastic activity during bone loss.
    Hikiji H; Ishii S; Yokomizo T; Takato T; Shimizu T
    Proc Natl Acad Sci U S A; 2009 Dec; 106(50):21294-9. PubMed ID: 19965376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl hydrocarbon receptor catabolic activity in bone metabolism is osteoclast dependent in vivo.
    Yu TY; Kondo T; Matsumoto T; Fujii-Kuriyama Y; Imai Y
    Biochem Biophys Res Commun; 2014 Jul; 450(1):416-22. PubMed ID: 24938130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
    Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K
    J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular expression of the chemokine CX3CL1 promotes osteoclast recruitment and exacerbates bone resorption in an irradiated murine model.
    Han KH; Ryu JW; Lim KE; Lee SH; Kim Y; Hwang CS; Choi JY; Han KO
    Bone; 2014 Apr; 61():91-101. PubMed ID: 24401612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.